« Back to Malignant Tumors of the Skin

Malignant Melanoma

»What is melanoma?
»How common is malignant melanoma in the United States?
»What causes melanoma?
»What groups have a genetic predisposition to familial melanoma?
»List the risk factors for melanoma.
»List the high-risk groups for developing melanoma.
»Do all melanomas develop from atypical nevi?
»What are cancer stem cells?
»Is melanoma a single disease?
»What are the molecular pathways in melanoma?
»Is there a host immune response to melanoma?
»Describe the clinical appearance of melanoma.
»What are the ABCDEs of melanoma?
»What is dermoscopy?
»Where on the body does melanoma most commonly arise?
»Are there different types of melanoma?
»What are Clark’s levels?
»What is Breslow’s depth?
»What other findings should be reported in the histopathologic diagnosis of melanoma?
»What are the common immunohistochemical (IHC) markers utilized in the diagnosis of melanoma?
»Are there other factors with prognostic impact in patients with melanoma?
»How are patients with melanoma evaluated after the initial diagnosis?
»What is the most current system for staging melanoma?
»How is melanoma treated?
»How wide should surgical margins be?
»What is the most important risk factor for local recurrence of primary melanoma?
»Does a biopsy of melanoma increase the risk of spreading tumor cells or causing metastases?
»Describe the recommended follow-up for a patient with melanoma.
»Which tests or examinations are conducted during the routine follow-up of patients who have had melanoma?
»Does local tumor recurrence influence overall survival?
»What is elective lymph node dissection (ELND)? When is it indicated?
»What is sentinel lymph node biopsy? When is it indicated?
»What is linear melanonychia?
»What is Hutchinson’s sign?
»What is Hutchinson’s freckle?
»Are there any new ways to assess prognosis in patients with melanoma?
»What forms of chemotherapy are used in the treatment of metastatic melanoma?
»Is radiation therapy effective for melanoma?
»How effective is immunotherapy in malignant melanoma?
»Does gene therapy offer any better results?
»How about local perfusion?
»What are some newer targeted therapies for melanoma?

 
 
 

How wide should surgical margins be?

There is ongoing controversy regarding the width of normal-appearing skin that should be excised. At one time, 5.0-cm margins were recommended. With the exception of only four prospective multicenter trials, surgical margins were originally based, at least in part, on consensus decision and tradition. A National Institutes of Health Consensus Conference on Melanoma has recommended surgical margins based on the depth of invasion of the primary tumor. Malignant melanoma in situ should be excised with a 0.5-cm border of normal skin. Lesions that have a Breslow’s depth of 1.0 mm should have wide local reexcision with 1.0-cm margins. Lesions that are 1 to 2 mm thick should be excised with 1- to 2-cm margins (2 cm, if primary closure can be achieved, or no significant difference exists in reconstruction between a 1- and 2-cm margin of excision). Lesions that are intermediate, 2 to 4 mm thick, are excised with 2-cm margins. Lesions 4.0 mm thick should be excised with 2- to 3-cm margins; there are no randomized trials that have determined the optimal margins for excision of melanoma >4 mm in thickness. These recommendations are meant only as general guidelines, and individual patient considerations must be taken into account. It should be stressed that there are several studies demonstrating that 0.5-cm margins are inadequate for most malignant melanoma in situ on the head, neck, hands, and feet. Moreover, there is evidence to suggest that tumor thickness should not influence surgical margins.


Studies suggest that definitive surgical treatment may be delayed up to 3 weeks after biopsy of the primary lesion without adversely affecting the 5-year survival rate.

Landthaler M, Braun-Falco O, Leitl A, et al: Excisional biopsy as the first therapeutic procedure versus primary wide excision of malignant melanoma, Cancer 64:1612–1616, 1989.

Zitelli JA: Surgical margins for lentigo maligna, Arch Dermatol 2004 140:607–608, 2004.

Bricca GM, Brodland DG, Ren D, Zitelli JA: Cutaneous head and neck melanoma treated with Mohs micrographic surgery, J Am Acad Dermatol 52:92–100, 2005.

Thompson JF, Scolyer RA, Uren RF: Surgical management of primary cutaneous melanoma: excision margins and the role of sentinel lymph node examination, Surg Oncol Clin N Am 15:301–318, 2006.